The breakdown of ingredients may pose safety risks, and the medication may not work as intended, potentially disrupting treatment plans and requiring adjustments
The main goal is appetite reduction and weight loss, though increased energy can be a welcome side effect for some people
Keywords: American Heart Association, AHA Annual Scientific Sessions, AHA24, ACC International, Obesity, Heart Failure, Preserved Ejection Fraction, Glucagon-Like Peptide-1 Receptor
[1] Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue, meaning that it mimics the naturally-occuring GLP-1 hormone to stabilise blood sugar levels, stimulate satiety and in turn, encourage weight loss
It also reduces appetite and promotes weight loss, which many patients find life-changing